Jean-Marie Stassen

Title: The Innovations of Jean-Marie Stassen

Introduction

Jean-Marie Stassen is a notable inventor based in Lubbeek, Belgium. He has made significant contributions to the field of medical technology, particularly in the area of therapeutic interventions. With a total of six patents to his name, Stassen's work has the potential to impact patient care and treatment outcomes.

Latest Patents

Stassen's latest patents include an innovative approach to anti-angiogenic therapy. This invention provides novel monoclonal antibodies directed to PlGF and fragments and derivatives thereof. More specifically, it focuses on humanized antibodies and fragments for use in the treatment and/or prevention of pathological angiogenesis. Another significant patent addresses a method for treating filtration failure after trabeculectomy surgery. This invention aims to improve the outcomes of trabeculectomy surgery by extending the lifetime of the sclera-corneal drainage channel. The improvement is achieved through post-surgical administration of plasmin or its active derivatives in the form of topical eye drops or anterior chamber injections.

Career Highlights

Throughout his career, Stassen has worked with prominent companies such as Thrombogenics NV and Vlaams Interuniversitair Instituut Voor Biotechnologie VZW. His work in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Stassen has collaborated with esteemed colleagues, including Peter Carmeliet and Uwe Joerg Ries. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of biotechnology.

Conclusion

Jean-Marie Stassen's contributions to medical technology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic interventions, ultimately benefiting patient care.